Eli Lilly & Co. $LLY has unveiled an ambitious plan to allocate a minimum of $27 billion towards establishing four new manufacturing plants across the United States. This strategic move comes in response to potential tariffs that could be introduced by President Donald Trump on the pharmaceutical sector.